drugset / Trial / NCT06053164

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

NCT06053164

RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators plan to conduct a study to find out if giving portable oxygen therapy (during physical activity) to patients with interstitial lung disease will improve quality of life, exercise tolerance, shortness of breath, and blood vessel function. Oxygen will be provided for a period of 8 weeks. Additionally, the investigators plan to investigate if it is helpful to deliver individualized support when providing oxygen therapy, through check-in phone calls with a respiratory therapist and by providing additional educational material.

Timeline

Start
2025-07-01
Primary completion
2026-09-01
Completion
2026-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified

Indications